Literature DB >> 12172249

A method to repair auricular defects after perichondrial cutaneous grafting.

Fred J Stucker1, Kenneth W Sanders.   

Abstract

OBJECTIVE: To describe and illustrate the technique for closing the auricular bowl defect after perichondrial cutaneous grafting. The postauricular flip-flop flap is used for this purpose. STUDY
DESIGN: A retrospective clinical study of 354 patients using the perichondrial cutaneous graft for various reconstructions of the face and then performing the postauricular flip-flop flap procedure.
METHODS: The perichondrial cutaneous graft is a reliable, versatile graft that possesses unique properties for reconstructive surgery of the face. The postauricular flip-flop flap is our particular technique for closure of the donor site wound after using the perichondrial cutaneous graft. It is a relatively simple procedure that has predictable results. We used this technique in patients ranging in age from 7 days to 92 years and noted excellent cosmetic results and rare complications.
RESULTS: Two patients had failure of the perichondrial cutaneous graft. Two patients had partial necrosis of the postauricular flip-flop flap. Two patients had dehiscence of the postauricular closure.
CONCLUSION: The postauricular flip-flop flap is a reliable method to repair the donor site after perichondrial cutaneous grafting.

Entities:  

Mesh:

Year:  2002        PMID: 12172249     DOI: 10.1097/00005537-200208000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Partial auricular reconstruction.

Authors:  Bob B Armin; Robert O Ruder; Babak Azizadeh
Journal:  Semin Plast Surg       Date:  2011-11       Impact factor: 2.314

2.  Clinical case-study describing the use of skin-perichondrium-cartilage graft from the auricular concha to cover large defects of the nose.

Authors:  Francesco Inchingolo; Marco Tatullo; Massimo Marrelli; Alessio D Inchingolo; Roberto Corelli; Angelo M Inchingolo; Gianna Dipalma; Fabio M Abenavoli
Journal:  Head Face Med       Date:  2012-03-19       Impact factor: 2.151

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.